XoZymes replaces traditional chemical production methods with an approach that integrates widely available feedstocks like sugar and biomass with advanced enzymes engineered to thrive outside living ...
A new article, published in the International Journal of Environmental Research and Public Health, unveils a software application that transforms patients' homes into therapeutic environments for ...
DMU will be part of a consortium laying the foundation for future medicines that are affordable, safe, effective, and ...
The 3D cell culture industry is poised for substantial growth from 2025 to 2035, driven by advancements in biotechnology and ...
The Pan American Health Organisation (PAHO) says disparity in access to treatment for childhood cancers is particularly ...
The USAN designation reflects Okyo Pharma’s commitment to developing new therapies for unmet medical needs in ophthalmology. The suffix “-mod” in urcosimod denotes its classification as a modulator of ...
The Generative AI in Drug Discovery Market was valued at USD 138.5 Million in 2023. It is expected to reach USD 1,435.0 Million by 2033, with a CAGR of 27.1% ...
The World Health Organization (WHO) and St. Jude Children’s Research Hospital have commenced distribution of ...
The World Health Organization (WHO) and St. Jude Children's Research Hospital have commenced distribution of critically-needed childhood cancer medicines in 2 of 6 pilot countries, through the Global ...
The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback